Galibier Capital Management Ltd. Cuts Position in Henry Schein, Inc. (NASDAQ:HSIC)

Galibier Capital Management Ltd. decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 19.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,476 shares of the company's stock after selling 10,000 shares during the period. Henry Schein comprises approximately 0.9% of Galibier Capital Management Ltd.'s holdings, making the stock its 19th largest position. Galibier Capital Management Ltd.'s holdings in Henry Schein were worth $2,841,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after buying an additional 1,898 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after buying an additional 395 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after buying an additional 678 shares in the last quarter. GAMMA Investing LLC lifted its stake in Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after purchasing an additional 1,081 shares in the last quarter. Finally, Wellington Management Group LLP lifted its stake in Henry Schein by 12.6% in the 4th quarter. Wellington Management Group LLP now owns 6,902 shares of the company's stock worth $478,000 after purchasing an additional 775 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 1.5%

NASDAQ:HSIC traded down $1.11 on Friday, hitting $73.42. The stock had a trading volume of 1,446,652 shares, compared to its average volume of 1,727,684. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.94 billion, a price-to-earnings ratio of 22.94, a PEG ratio of 2.37 and a beta of 0.87. The company has a fifty day moving average price of $71.56 and a two-hundred day moving average price of $71.33. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the firm earned $1.10 EPS. The firm's revenue for the quarter was down .1% on a year-over-year basis. Equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have commented on HSIC shares. Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Evercore ISI upped their target price on shares of Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a research report on Wednesday. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Piper Sandler decreased their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $79.70.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.